TY - JOUR
T1 - Diffusion basis spectrum imaging detects axonal injury in the optic nerve following traumatic brain injury
AU - Lavadi, Raj Swaroop
AU - Utt, Kainen L.
AU - Housley, Stephen N.
AU - Nouduri, Sirisha
AU - Lin, Tsen-Hsuan Abby""
AU - Blum, Jacob
AU - Pennicooke, Brenton H.
AU - Song, Sheng Kwei
AU - Agarwal, Nitin
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/10
Y1 - 2025/10
N2 - Purpose: To utilize diffusion basis spectrum imaging (DBSI), an advanced imaging modality that has been shown to distinguish between co-occurring white matter pathologies, to discern changes in the optic nerves among patients with traumatic brain injury (TBI). Methods: Seven patients with TBI were prospectively recruited to undergo a 3 T magnetic resonance imaging brain scan within two months of injury, and follow-up scans at 6- and 12-months. The optic nerve was considered the region of interest. Manual alignment of the optic nerve slices was performed, followed by the deployment of an in-house script to obtain post-processed data. Diffusion tensor imaging and DBSI-derived axial (AD) and radial diffusivity (RD), reflecting axon and myelin integrity, respectively, were compared. DBSI-derived signal intensities were also compared. The Kruskal-Wallis test was performed to determine significance (p < 0.05). Results: Fourteen optic nerves from patients were compared with 18 optic nerves from control participants. The values of DTI RD were significantly greater among patients than controls (p < 0.05) across all timepoints, with no corresponding differences in the AD. However, a decrease in DBSI AD (p < 0.01) observed only at the initial scan, coupled with a stable RD, was observed among patients. Comparisons between DBSI signal intensities among patients showed no appreciable differences; however, the fiber fraction was significantly lower (p < 0.05) at all timepoints. Conclusion: Acute reductions in DBSI-derived AD and sustained reductions in fiber fraction can serve as a potential biomarker for axonal injury in the optic nerves of patients with TBI.
AB - Purpose: To utilize diffusion basis spectrum imaging (DBSI), an advanced imaging modality that has been shown to distinguish between co-occurring white matter pathologies, to discern changes in the optic nerves among patients with traumatic brain injury (TBI). Methods: Seven patients with TBI were prospectively recruited to undergo a 3 T magnetic resonance imaging brain scan within two months of injury, and follow-up scans at 6- and 12-months. The optic nerve was considered the region of interest. Manual alignment of the optic nerve slices was performed, followed by the deployment of an in-house script to obtain post-processed data. Diffusion tensor imaging and DBSI-derived axial (AD) and radial diffusivity (RD), reflecting axon and myelin integrity, respectively, were compared. DBSI-derived signal intensities were also compared. The Kruskal-Wallis test was performed to determine significance (p < 0.05). Results: Fourteen optic nerves from patients were compared with 18 optic nerves from control participants. The values of DTI RD were significantly greater among patients than controls (p < 0.05) across all timepoints, with no corresponding differences in the AD. However, a decrease in DBSI AD (p < 0.01) observed only at the initial scan, coupled with a stable RD, was observed among patients. Comparisons between DBSI signal intensities among patients showed no appreciable differences; however, the fiber fraction was significantly lower (p < 0.05) at all timepoints. Conclusion: Acute reductions in DBSI-derived AD and sustained reductions in fiber fraction can serve as a potential biomarker for axonal injury in the optic nerves of patients with TBI.
KW - Biomarker
KW - Diffusion basis spectrum imaging
KW - Traumatic brain injury
KW - White matter injury
UR - https://www.scopus.com/pages/publications/105010874121
U2 - 10.1016/j.mri.2025.110451
DO - 10.1016/j.mri.2025.110451
M3 - Article
C2 - 40609711
AN - SCOPUS:105010874121
SN - 0730-725X
VL - 122
JO - Magnetic Resonance Imaging
JF - Magnetic Resonance Imaging
M1 - 110451
ER -